BenchSci was conceived by a scientist studying at the University of Toronto, Dr. Thomas Leung, in 2015.
While completing his PhD project on cancer epigenetics, Tom was frustrated by the inefficient process of manually finding validated reagents from the literature. This often took him days, even for commonly used reagents such as antibodies.
Tom’s vision was to liberate scientists like himself from mundane tasks such as reading paper after paper just to find the reagents they need, so they can focus on designing and performing experiments for life-saving discoveries.
To realize his vision, Tom recruited co-founders David Chen (CTO), Liran Belenzon (CEO), and Elvis Wianda (CDO), and started BenchSci.
You can learn more here: https://www.benchsci.com/press/.